Rubicon Organics Inc (ROMJF)
0.30
+0.02
(+7.03%)
USD |
OTCM |
May 17, 13:26
Rubicon Organics Total Liabilities (Quarterly): 12.83M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 12.83M |
| June 30, 2023 | 13.61M |
| March 31, 2023 | 12.37M |
| December 31, 2022 | 13.10M |
| September 30, 2022 | 12.28M |
| June 30, 2022 | 12.45M |
| March 31, 2022 | 12.39M |
| December 31, 2021 | 12.50M |
| September 30, 2021 | 12.58M |
| June 30, 2021 | 11.47M |
| March 31, 2021 | 13.00M |
| Date | Value |
|---|---|
| December 31, 2020 | 17.43M |
| September 30, 2020 | 14.88M |
| June 30, 2020 | 13.40M |
| March 31, 2020 | 18.81M |
| December 31, 2019 | 16.28M |
| September 30, 2019 | 12.53M |
| June 30, 2019 | 11.72M |
| March 31, 2019 | 7.270M |
| December 31, 2018 | 4.602M |
| September 30, 2018 | 4.921M |
| December 31, 2017 | 4.159M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
11.47M
Minimum
Jun 2021
18.81M
Maximum
Mar 2020
13.53M
Average
12.70M
Median
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
| Lexaria Bioscience Corp | 0.2042M |
| Xenon Pharmaceuticals Inc | 31.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.00M |
| Shareholders Equity (Quarterly) | 27.18M |
| Debt to Equity Ratio | 0.2872 |
| Current Ratio | 3.479 |
| Net Debt Paydown Yield | 7.59% |